Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cyclohexanamine, N-cyclohexyl-, Sulfate (1:1)
2. Dicyclohexylamine Hydrochloride
3. Dicyclohexylamine Nitrate
4. Dicyclohexylamine Nitrite
5. Dicyclohexylamine Phosphate (3:1)
6. Dicyclohexylamine Sulfate
7. Dicyclohexylamine Sulfate (1:1)
8. Dicyclohexylammonium
1. 101-83-7
2. N-cyclohexylcyclohexanamine
3. Cyclohexanamine, N-cyclohexyl-
4. Dcha
5. N,n-dicyclohexylamine
6. Dicha
7. Dodecahydrodiphenylamine
8. Dicyklohexylamin
9. N,n-diclohexylamine
10. N-cyclohexyl-cyclohexylamine
11. Dicyklohexylamin [czech]
12. Nsc 3399
13. Ccris 6228
14. Hsdb 4018
15. Einecs 202-980-7
16. Un2565
17. Unii-1a93rjw924
18. Brn 0605923
19. Mls002174250
20. Chebi:34694
21. Ai3-15334
22. 1a93rjw924
23. Dsstox_cid_5018
24. Dsstox_rid_77630
25. Dsstox_gsid_25018
26. Ncgc00090955-03
27. Smr001224510
28. Dch
29. Nsc-3399
30. Cas-101-83-7
31. Dicydohexylamine
32. Dicylohexylamine
33. Dicylcohexylamine
34. Aminodicyclohexane
35. Di-cyclohexylamine
36. Dicyclohexyl-amine
37. Dicyclohexyl Amine
38. Bis-cyclohexylamine
39. Bis(cyclohexyl)amine
40. Cy2nh
41. Cyclohexylcyclohexanamine
42. Dicyclohexylamine, 99%
43. Ac-
44. A-ala-oh.dcha
45. Dicyclohexylamine, 99+%
46. Schembl500
47. Ec 202-980-7
48. Cid_7582
49. Nciopen2_002862
50. Oprea1_024913
51. N,n-dicyclohxyl-amine
52. 4-12-00-00022 (beilstein Handbook Reference)
53. Mls002152900
54. Bidd:er0258
55. Dicyclohexylamine [mi]
56. Wln: L6tj Am-al6tj
57. Dicyclohexylamine [hsdb]
58. Chembl1451838
59. Dtxsid6025018
60. Bdbm74256
61. Nsc3399
62. Hms3741i15
63. Zinc982093
64. Str04129
65. Tox21_111044
66. Tox21_201771
67. Tox21_303097
68. Bbl002970
69. Mfcd00011658
70. Stk379549
71. Dicyclohexylamine, Analytical Standard
72. Akos000119059
73. Tox21_111044_1
74. Un 2565
75. Ncgc00090955-01
76. Ncgc00090955-02
77. Ncgc00090955-04
78. Ncgc00090955-05
79. Ncgc00090955-06
80. Ncgc00257081-01
81. Ncgc00259320-01
82. Dicyclohexylamine Dodecahydro Diphenylamine
83. Dicyclohexylamine [un2565] [corrosive]
84. Ds-002441
85. Ds-002442
86. D0435
87. Ft-0624742
88. A11830
89. Ag-617/02036022
90. Q425368
91. J-000503
92. F2190-0312
| Molecular Weight | 181.32 g/mol |
|---|---|
| Molecular Formula | C12H23N |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 181.183049738 g/mol |
| Monoisotopic Mass | 181.183049738 g/mol |
| Topological Polar Surface Area | 12 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 116 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
4. 4= VERY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) 50-500 MG/KG, BETWEEN 1 TEASPOON & 1 OZ FOR 70 KG PERSON (150 LB).
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-139
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
THIRTY-FIVE TO FORTY PER CENT OF SODIUM SALT OF CYCLOHEXAMIC ACID IS ELIMINATED THROUGH KIDNEYS.
PMID:5129945 GOETTINGER E; WIEN MED WOCHENSCHR 121 (25-26): 515-516 (1971)
UP TO 40% IS CHANGED INTO CYCLOHEXAMINE IN HUMANS & TO LESSER EXTENT INTO DICYCLOHEXAMINE.
PMID:5129945 GOETTINGER E; WIEN MED WOCHENSCHR 121 (25-26): 515-516 (1971)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
56
PharmaCompass offers a list of Dicyclohexylamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dicyclohexylamine manufacturer or Dicyclohexylamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dicyclohexylamine manufacturer or Dicyclohexylamine supplier.
PharmaCompass also assists you with knowing the Dicyclohexylamine API Price utilized in the formulation of products. Dicyclohexylamine API Price is not always fixed or binding as the Dicyclohexylamine Price is obtained through a variety of data sources. The Dicyclohexylamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EINECS 202-980-7 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EINECS 202-980-7, including repackagers and relabelers. The FDA regulates EINECS 202-980-7 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EINECS 202-980-7 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EINECS 202-980-7 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EINECS 202-980-7 supplier is an individual or a company that provides EINECS 202-980-7 active pharmaceutical ingredient (API) or EINECS 202-980-7 finished formulations upon request. The EINECS 202-980-7 suppliers may include EINECS 202-980-7 API manufacturers, exporters, distributors and traders.
click here to find a list of EINECS 202-980-7 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
EINECS 202-980-7 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EINECS 202-980-7 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EINECS 202-980-7 GMP manufacturer or EINECS 202-980-7 GMP API supplier for your needs.
A EINECS 202-980-7 CoA (Certificate of Analysis) is a formal document that attests to EINECS 202-980-7's compliance with EINECS 202-980-7 specifications and serves as a tool for batch-level quality control.
EINECS 202-980-7 CoA mostly includes findings from lab analyses of a specific batch. For each EINECS 202-980-7 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EINECS 202-980-7 may be tested according to a variety of international standards, such as European Pharmacopoeia (EINECS 202-980-7 EP), EINECS 202-980-7 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EINECS 202-980-7 USP).
